Dr. Goff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
177 Fort Washington Ave
MHB 7GS 313
New York, NY 10032Phone+1 813-787-4286
Education & Training
- Brigham and Women's HospitalFellowship, Complex General Surgical Oncology, 2012 - 2014
- Massachusetts General HospitalFellowship, Complex General Surgical Oncology, 2012 - 2014
- New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 2009 - 2012
- National Cancer InstituteFellowship, Tumor Immunology, 2005 - 2009
- New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Surgery, 2003 - 2005
- University of South Florida College of MedicineClass of 2003
Certifications & Licensure
- NY State Medical License 2005 - 2025
- MA State Medical License 2012 - 2018
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 393 citationsLymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 LevelsJames N. Kochenderfer, Robert Somerville, Tangying Lu, Victoria Shi, Adrian Bot
Journal of Clinical Oncology. 2017-03-14 - 285 citationsStem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancerSri Krishna, Frank J. Lowery, Amy R. Copeland, Erol Bahadiroglu, Ratnadeep Mukherjee
Science. 2020-12-11 - 78 citationsA phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.Ken-Ichi Hanada, Chihao Zhao, Raul Gil-Hoyos, Jared J Gartner, Christopher Chow-Parmer
Cancer Cell. 2022-05-09
Press Mentions
- Understanding the Risk of Second Cancers After CAR T-cell TherapyAugust 13th, 2024
- Evidence Mounting for TILs as Possible First-Line Cancer TherapySeptember 24th, 2021
- Adoptive Transfer of Tumor-Infiltrating Lymphocytes May Be Less Effective in Patients with Pretreated Metastatic MelanomaAugust 18th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: